Beth Blane

TL;DR: A post-hoc analysis of the efficacy of the adenoviral vector vaccine, ChAdOx1 nCoV-19 (AZD1222), against B.1.7, emerged as the dominant cause of COVID-19 disease in the UK from November, 2020 as discussed by the authors.

TL;DR: In this paper, the authors compared the severity of the delta variant compared with the alpha variant by determining the relative risk of hospital attendance outcomes and found that outbreaks of the Delta variant in unvaccinated populations might lead to a greater burden on health-care services than the alpha variants.

TL;DR: In this article , the authors demonstrate substantial evasion of neutralization by Omicron BA.1 and BA.2 variants in vitro using sera from individuals vaccinated with ChAdOx1, BNT162b2 and mRNA-1273.529.

TL;DR: There was limited evidence that antimicrobial-resistant pathogens associated with serious human infection had originated from livestock in the authors' region, according to analysis of mobile genetic elements and long-read sequencing.

TL;DR: The results suggest that different clones may have adopted different strategies to overcome host responses and cause severe pathology, and the use of a combined genomics and data analytic approach to enhance the understanding of bacterial pathogenesis at the individual level, which will be an important step towards personalized medicine and infectious disease management.